Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II/III data support teriflunomide monotherapy for relapsing MS

Oct. 25, 2010

Telatinib shows promise in patients with cancer of the stomach or gastroesophageal junction

Oct. 25, 2010

Firategrast suppresses onset of new lesions in relapsing-remitting MS

Oct. 25, 2010

OBA-19 offers neuroprotection in model of ischemic stroke

Oct. 25, 2010

In vivo data support clinical development of VX15/2503 for MS

Oct. 25, 2010

Scientists identify potential biomarkers of delirium in ICU patients

Oct. 22, 2010

DHOdehase inhibitor LAS-186323 shows favorable safety and pharmacokinetics

Oct. 22, 2010

Continued benefit seen with 4-year odanacatib therapy in postmenopausal women

Oct. 22, 2010

Phase II trials assess Amgen's antibodies in pancreatic and non-small cell lung cancer

Oct. 22, 2010

Oncolytic vaccinia virus GL-ONC1 well tolerated in patients with solid cancers

Oct. 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.